New weapon against superbug pneumonia and blood infections
NCT ID NCT07431307
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new antibiotic combination (BV100 plus other drugs) against hard-to-treat infections like pneumonia and bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii. About 120 adults in the hospital will receive either the new combo or the best available treatment. The goal is to see if the new combo is safer and works better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD STREAM INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new antibiotic outmatch an old one against Drug-Resistant pneumonia?
- New antibiotic YK-1169 takes on deadly hospital pneumonia
- Can talk therapy tame brain Injury's emotional storm?
- Oral vs. needle: which stops Kids' seizures faster?
- Could a Mitochondria-Boosting supplement beat multivitamins for preventing colds?
- Scientists probe how meningitis vaccines spark immunity